Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does the Addition of Liposomal Bupivacaine to the Adductor Canal Block Impact Narcotic Use After Primary Total Knee Arthroplasty: a Prospective, Blind Randomized Control Trial

NCT04539730 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT04539730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04539730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does the Addition of Liposomal Bupivacaine to the Adductor Canal Block Impact Narcotic Use After Primary Total Knee Arthroplasty: a Prospective, Blind Randomized Control Trial
Lead sponsor
University of Miami
Phase
Phase 4
Overall status
Withdrawn
Start date
December 1, 2021
Completion date
December 1, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adductor canal block, arthroplasty complications, opioid use, peripheral nerve block